Affinity Asset Advisors »

Veradermics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Veradermics (MANE) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Veradermics

Tip: Access up to 7 years of quarterly data

All positions including Veradermics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veradermics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.4M 70k 63.15

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Veradermics

Suvretta Capital Management
Sr One Capital Management
Citadel Advisors
FMR
Viking Global Investors
Siren
Adage Capital Partners GP
Standard Life Aberdeen
Infinitum Asset Management
Vanguard Capital Management
Marshall Wace
Balyasny Asset Management
Paradigm Biocapital Advisors
Ameriprise Financial
Woodline Partners

View all funds holding Veradermics